Reaching proof of concept

By BC Staff | Mar 26, 2007 | 7:00 AM GMT

Reaching proof of concept

Obesity
Company Product Description Target/ Mechanism Milestones
Alizyme Cetilistat (ATL-962) Lipase inhibitor Lipase Start Ph III 1H07 (A)
Amylin Pramlintide/leptin Synthetic amylin analog/recombinant leptin Amylin receptor/leptin receptor Ph II data 07

Read the full 367 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE